한글목차

마이크로바이옴 시퀀싱 서비스 시장 규모는 2025년 31억 4,000만 달러에서 2034년에는 158억 5,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 19.72%로 성장할 전망입니다.

인간의 건강과 질병에서 마이크로바이옴의 역할에 대한 인식이 높아짐에 따라 마이크로바이옴 시퀀싱 서비스 시장이 크게 성장할 것으로 예측됩니다. 미생물 군집과 다양한 건강 상태와의 복잡한 관계가 연구를 통해 계속 밝혀지고 있는 가운데, 마이크로바이옴 시퀀싱 서비스에 대한 수요가 급증하고 있습니다. 이러한 서비스를 통해 연구자와 의료진은 인체내 미생물 군집의 구성과 기능을 분석하여 비만, 당뇨병, 염증성 장 질환 등의 질병에 미치는 영향에 대한 지식 습득을 촉진하고 있습니다. 차세대 염기서열 분석(NGS)과 메타유전체을 포함한 염기서열 분석 기술의 혁신으로 마이크로바이옴 분석의 정확성과 효율성이 향상되어 보다 광범위한 응용 분야에서 활용이 가능해졌습니다.

또한 맞춤형 의료에 대한 관심이 높아지면서 마이크로바이옴 시퀀싱 서비스 시장에도 영향을 미치고 있습니다. 의료 서비스 프로바이더가 개인별 마이크로바이옴 프로파일을 기반으로 치료법을 조정함에 따라 종합적인 시퀀싱 서비스에 대한 수요가 증가할 것으로 예측됩니다. 이러한 추세는 프로바이오틱스 및 마이크로바이옴 기반 치료법 개발에서 특히 중요하며, 환자의 고유한 미생물 구성을 이해함으로써 보다 효과적인 개입이 가능해집니다. 또한 생물정보학 툴와 머신러닝 알고리즘의 통합으로 데이터 분석 능력이 향상되어 마이크로바이옴의 동학과 건강에 미치는 영향에 대한 심층적인 인사이트을 얻을 수 있게 되었습니다.

또한 예방의학 및 웰니스에 대한 관심이 높아지면서 마이크로바이옴 조사에 대한 관심이 높아지고 있습니다. 소비자들은 장내 환경의 중요성과 전신 건강 상태와의 연관성을 더욱 인식하게 되면서 마이크로바이옴 검사 서비스에 대한 수요가 급증하고 있습니다. 개인용 검사 키트의 보급도 시장 성장에 기여하고 있으며, 개인이 자신의 마이크로바이옴 프로파일을 이해하고 정보에 입각한 생활습관 선택을 하려는 움직임이 확산되고 있습니다. 요약하면, 마이크로바이옴 시퀀싱 서비스 시장은 기술 발전, 맞춤형 의료에 대한 관심, 그리고 마이크로바이옴이 인체 건강에 미치는 역할에 대한 이해 증진 노력으로 인해 견고한 성장이 예상됩니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : SEQUENCING BY LIGATION(SBL)별

제5장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 실험실 유형별

제6장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 조사 유형별

제7장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 용도별

제8장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 최종사용자별

제9장 세계의 마이크로바이옴 시퀀싱 서비스 시장 : 지역별

제10장 경쟁 구도

제11장 기업 개요

영문목차

The Microbiome Sequencing Services Market size is expected to reach USD 15.85 Billion in 2034 from USD 3.14 Billion (2025) growing at a CAGR of 19.72% during 2026-2034.

The microbiome sequencing services market is poised for significant growth, driven by the increasing recognition of the human microbiome's role in health and disease. As research continues to unveil the complex relationships between microbial communities and various health conditions, the demand for microbiome sequencing services is surging. These services enable researchers and healthcare providers to analyze the composition and function of microbial populations in the human body, facilitating insights into their impact on diseases such as obesity, diabetes, and inflammatory bowel disease. Innovations in sequencing technologies, including next-generation sequencing (NGS) and metagenomics, are enhancing the accuracy and efficiency of microbiome analysis, making it more accessible to a broader range of applications.

Moreover, the growing emphasis on personalized medicine is influencing the microbiome sequencing services market. As healthcare providers seek to tailor treatments based on individual microbiome profiles, the demand for comprehensive sequencing services is expected to rise. This trend is particularly relevant in the development of probiotics and microbiome-based therapies, where understanding the unique microbial composition of patients can lead to more effective interventions. Additionally, the integration of bioinformatics tools and machine learning algorithms is enhancing data analysis capabilities, allowing for deeper insights into microbiome dynamics and their implications for health.

Furthermore, the increasing focus on preventive healthcare and wellness is driving interest in microbiome research. Consumers are becoming more aware of the importance of gut health and its connection to overall well-being, leading to a surge in demand for microbiome testing services. The rise of direct-to-consumer testing kits is also contributing to market growth, as individuals seek to understand their microbiome profiles and make informed lifestyle choices. In summary, the microbiome sequencing services market is set for robust expansion, characterized by technological advancements, a focus on personalized health, and a commitment to enhancing our understanding of the microbiome's role in human health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

Sequencing By Ligation (SBL)

Pyrosequencing

Sanger Sequencing

Others

ByA Laboratory Type

Dry labs

Wet Labs

By Research Type

• Outsourced Research
• Internal Research
• ByA Application
• Shotgun Sequencing
• Targeted Gene Sequencing
• RNA Sequencing
• Whole Genome Sequencing
• Other
• ByA End User
• Research and Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Others

COMPANIES PROFILED

• Baseclear BV, Zymo Research Corporation, Second Genome, MR DNA Molecular Research LP, Microbiome Insights, Mrieux NutriSciences Corporation, ClinicalMicrobiomics AS, Rancho BioSciences, Diversigen, Molzym GmbH Co KG, BioSpherex LLC, Tgen

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY SEQUENCING BY LIGATION (SBL) 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Sequencing By Ligation (sbl)
• 4.2. Pyrosequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sanger Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY LABORATORY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Laboratory Type
• 5.2. Dry labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wet Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY RESEARCH TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Research Type
• 6.2. Outsourced Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Internal Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Shotgun Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Targeted Gene Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. RNA Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Whole Genome Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Research and Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Sequencing By Ligation (sbl)
  • 9.2.2 By Laboratory Type
  • 9.2.3 By Research Type
  • 9.2.4 By Application
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Sequencing By Ligation (sbl)
  • 9.3.2 By Laboratory Type
  • 9.3.3 By Research Type
  • 9.3.4 By Application
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Sequencing By Ligation (sbl)
  • 9.4.2 By Laboratory Type
  • 9.4.3 By Research Type
  • 9.4.4 By Application
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Sequencing By Ligation (sbl)
  • 9.5.2 By Laboratory Type
  • 9.5.3 By Research Type
  • 9.5.4 By Application
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Sequencing By Ligation (sbl)
  • 9.6.2 By Laboratory Type
  • 9.6.3 By Research Type
  • 9.6.4 By Application
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL MICROBIOME SEQUENCING SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Baseclear B.V
  • 11.2.2 Zymo Research Corporation
  • 11.2.3 Second Genome
  • 11.2.4 MR DNA (Molecular Research LP)
  • 11.2.5 Microbiome Insights
  • 11.2.6 MAfA(C)Rieux NutriSciences Corporation
  • 11.2.7 Clinical-Microbiomics A/S
  • 11.2.8 Rancho BioSciences
  • 11.2.9 Diversigen
  • 11.2.10 Molzym GmbH & Co. KG
  • 11.2.11 BioSpherex LLC
  • 11.2.12 Tgen